Other news Stine Krag Brunvold 6/13/22 Other news Stine Krag Brunvold 6/13/22 NMD Pharma will be taking part in BIO 2022 Read More Other news Stine Krag Brunvold 5/16/22 Other news Stine Krag Brunvold 5/16/22 Meet us at Bio€quity 2022 Read More Press release Stine Krag Brunvold 5/10/22 Press release Stine Krag Brunvold 5/10/22 NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer Read More Press release Stine Krag Brunvold 5/3/22 Press release Stine Krag Brunvold 5/3/22 NMD Pharma expands its US presence Read More Other news Stine Krag Brunvold 4/28/22 Other news Stine Krag Brunvold 4/28/22 NMD Pharma meets with the Danish Chamber of Commerce Read More Other news Stine Krag Brunvold 4/20/22 Other news Stine Krag Brunvold 4/20/22 We will be taking part in the ICFSR conference Read More Other news Stine Krag Brunvold 4/6/22 Other news Stine Krag Brunvold 4/6/22 NMD Pharma will be attending DKBIO Read More Other news Stine Krag Brunvold 3/21/22 Other news Stine Krag Brunvold 3/21/22 NMD Pharma formår igen at rejse kapital – ser muligheder i bedre offentligt-privat samarbejde Read More Other news Stine Krag Brunvold 3/15/22 Other news Stine Krag Brunvold 3/15/22 Sachs 5th Annual Neuroscience Innovation Forum Read More Other news Stine Krag Brunvold 3/3/22 Other news Stine Krag Brunvold 3/3/22 Welcome to David Evans Read More Other news Stine Krag Brunvold 2/24/22 Other news Stine Krag Brunvold 2/24/22 Welcome to Sabine Dandiguian Read More Press release Stine Krag Brunvold 2/15/22 Press release Stine Krag Brunvold 2/15/22 NMD Pharma Raises €35 Million in a new Financing Read More Other news Stine Krag Brunvold 12/16/21 Other news Stine Krag Brunvold 12/16/21 Join us virtually for BIO Partnering at JPM January 10-14, 2022 Read More Press release Stine Krag Brunvold 7/8/21 Press release Stine Krag Brunvold 7/8/21 NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease Read More Press release Stine Krag Brunvold 6/30/21 Press release Stine Krag Brunvold 6/30/21 NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670 Read More Insights Stine Krag Brunvold 6/25/21 Insights Stine Krag Brunvold 6/25/21 Interview with Professor, Dr. Geert Jan Groeneveld about myasthenia gravis Read More Press release Stine Krag Brunvold 6/1/21 Press release Stine Krag Brunvold 6/1/21 NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults Read More Other news Stine Krag Brunvold 5/28/21 Other news Stine Krag Brunvold 5/28/21 Muscular chloride channel inhibition improves neuromuscular function Read More Other news Stine Krag Brunvold 4/29/21 Other news Stine Krag Brunvold 4/29/21 Sachs 4th Annual Neuroscience Innovation Forum Read More Other news Stine Krag Brunvold 2/17/21 Other news Stine Krag Brunvold 2/17/21 The first Oligonucleotides for CNS It all begins with an idea. Read More Newer Posts Older Posts
Other news Stine Krag Brunvold 6/13/22 Other news Stine Krag Brunvold 6/13/22 NMD Pharma will be taking part in BIO 2022 Read More
Other news Stine Krag Brunvold 5/16/22 Other news Stine Krag Brunvold 5/16/22 Meet us at Bio€quity 2022 Read More
Press release Stine Krag Brunvold 5/10/22 Press release Stine Krag Brunvold 5/10/22 NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer Read More
Press release Stine Krag Brunvold 5/3/22 Press release Stine Krag Brunvold 5/3/22 NMD Pharma expands its US presence Read More
Other news Stine Krag Brunvold 4/28/22 Other news Stine Krag Brunvold 4/28/22 NMD Pharma meets with the Danish Chamber of Commerce Read More
Other news Stine Krag Brunvold 4/20/22 Other news Stine Krag Brunvold 4/20/22 We will be taking part in the ICFSR conference Read More
Other news Stine Krag Brunvold 4/6/22 Other news Stine Krag Brunvold 4/6/22 NMD Pharma will be attending DKBIO Read More
Other news Stine Krag Brunvold 3/21/22 Other news Stine Krag Brunvold 3/21/22 NMD Pharma formår igen at rejse kapital – ser muligheder i bedre offentligt-privat samarbejde Read More
Other news Stine Krag Brunvold 3/15/22 Other news Stine Krag Brunvold 3/15/22 Sachs 5th Annual Neuroscience Innovation Forum Read More
Other news Stine Krag Brunvold 3/3/22 Other news Stine Krag Brunvold 3/3/22 Welcome to David Evans Read More
Other news Stine Krag Brunvold 2/24/22 Other news Stine Krag Brunvold 2/24/22 Welcome to Sabine Dandiguian Read More
Press release Stine Krag Brunvold 2/15/22 Press release Stine Krag Brunvold 2/15/22 NMD Pharma Raises €35 Million in a new Financing Read More
Other news Stine Krag Brunvold 12/16/21 Other news Stine Krag Brunvold 12/16/21 Join us virtually for BIO Partnering at JPM January 10-14, 2022 Read More
Press release Stine Krag Brunvold 7/8/21 Press release Stine Krag Brunvold 7/8/21 NMD Pharma Initiates ESTABLISH Study in Patients with Charcot-Marie-Tooth Disease Read More
Press release Stine Krag Brunvold 6/30/21 Press release Stine Krag Brunvold 6/30/21 NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670 Read More
Insights Stine Krag Brunvold 6/25/21 Insights Stine Krag Brunvold 6/25/21 Interview with Professor, Dr. Geert Jan Groeneveld about myasthenia gravis Read More
Press release Stine Krag Brunvold 6/1/21 Press release Stine Krag Brunvold 6/1/21 NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on Neuromuscular Transmission in Older Adults Read More
Other news Stine Krag Brunvold 5/28/21 Other news Stine Krag Brunvold 5/28/21 Muscular chloride channel inhibition improves neuromuscular function Read More
Other news Stine Krag Brunvold 4/29/21 Other news Stine Krag Brunvold 4/29/21 Sachs 4th Annual Neuroscience Innovation Forum Read More
Other news Stine Krag Brunvold 2/17/21 Other news Stine Krag Brunvold 2/17/21 The first Oligonucleotides for CNS It all begins with an idea. Read More
